Revolution Medicines (RVMD) Selling, General & Administrative (2019 - 2026)
Revolution Medicines' Selling, General & Administrative was $110.21 million in Q2 2026, up 171.6% from $40.58 million a year earlier and up 8.9% from the prior quarter.
Powered by 
Analysis
Revolution Medicines (RVMD) Selling, General & Administrative (2019 - 2026) Analysis & Trends
On a trailing twelve-month basis, Revolution Medicines' Selling, General & Administrative was $330.91 million through Jun 30, 2026, up 159.0% year-over-year; for FY2025, it was $195.04 million, up 100.5% from FY2024.
- Selling, General & Administrative has now increased for seven consecutive years, with a five-year compound annual growth rate of 55.5% (FY2020 to FY2025).
- In earlier years, Selling, General & Administrative was $97.3 million in FY2024 (+28.7%), $75.62 million in FY2023 (+86.3%), $40.59 million in FY2022 (+33.3%) and $30.45 million in FY2021 (+42.1%).
- The Q2 2026 figure marks the highest quarterly Selling, General & Administrative in data going back to Q1 2019.
- Compared with a year earlier, Selling, General & Administrative has increased for six straight quarters, with growth averaging 99.9% over the last eight quarters.
- The best year-over-year quarter for Selling, General & Administrative over five years was Q4 2023 (growth of 195.5%); the worst was Q4 2024 (a decline of 12.5%).
- Per Business Quant data, RVMD's Selling, General & Administrative in the three quarters before Q2 2026 was $101.25 million (Q1 2026), $66.68 million (Q4 2025) and $52.76 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | 3.24 Bn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | 5.65 Bn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Revolution Medicines | 37.70 Bn | 27.90 Bn | - | 110.21 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 110.21 Mn |
| Mar 31, 2026 | 101.25 Mn |
| Dec 31, 2025 | 66.68 Mn |
| Sep 30, 2025 | 52.76 Mn |
| Jun 30, 2025 | 40.58 Mn |
| Mar 31, 2025 | 35.01 Mn |
| Dec 31, 2024 | 28.21 Mn |
| Sep 30, 2024 | 23.96 Mn |
| Jun 30, 2024 | 21.71 Mn |
| Mar 31, 2024 | 22.84 Mn |
| Dec 31, 2023 | 32.24 Mn |
| Sep 30, 2023 | 15.51 Mn |
| Jun 30, 2023 | 14.64 Mn |
| Mar 31, 2023 | 13.22 Mn |
| Dec 31, 2022 | 10.91 Mn |
| Sep 30, 2022 | 10.43 Mn |
| Jun 30, 2022 | 10.20 Mn |
| Mar 31, 2022 | 9.04 Mn |
| Dec 31, 2021 | 8.69 Mn |
| Sep 30, 2021 | 7.79 Mn |
API Access
Revolution Medicines Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=RVMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "RVMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=RVMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();